496 results on '"De Felice, Fernanda G."'
Search Results
2. Alzheimer’s disease biomarkers and their current use in clinical research and practice
3. Changes in social environment impact primate gut microbiota composition
4. Defective regulation of the eIF2-eIF2B translational axis underlies depressive-like behavior in mice and correlates with major depressive disorder in humans
5. Changes in neuroinflammatory biomarkers correlate with disease severity and neuroimaging alterations in patients with COVID-19 neurological complications
6. Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice
7. Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for COVID-19 in Brazil
8. Dementia in Latin America: Paving the way toward a regional action plan.
9. AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models
10. The impact of SARS‐CoV‐2 in dementia across Latin America: A call for an urgent regional plan and coordinated response
11. Inflammation at the crossroads of COVID-19, cognitive deficits and depression
12. Impaired insulin signalling and allostatic load in Alzheimer disease
13. Lung inflammation induced by silica particles triggers hippocampal inflammation, synapse damage and memory impairment in mice
14. The crosstalk between brain and periphery: Implications for brain health and disease
15. Type I Hsp40s/DnaJs aggregates exhibit features reminiscent of amyloidogenic structures.
16. Prospects and challenges in using neuronal extracellular vesicles in biomarker research.
17. Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease
18. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System
19. Leptin receptor reactivation restores brain function in early-life Lepr-deficient mice
20. Structural changes in the obese brain
21. Palmitate Is Increased in the Cerebrospinal Fluid of Humans with Obesity and Induces Memory Impairment in Mice via Pro-inflammatory TNF-α
22. Interleukin-1β mediates alterations in mitochondrial fusion/fission proteins and memory impairment induced by amyloid-β oligomers
23. Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants
24. Understanding the link between insulin resistance and Alzheimer’s disease: Insights from animal models
25. Alzheimer‐associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation
26. The ketamine metabolite (2R,6R)‐hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer's disease.
27. Correction of mTORC1‐mediated brain protein synthesis rescues memory in mouse models of Alzheimer’s disease
28. Synaptic proteasome is inhibited in Alzheimer’s disease models and is associated with memory impairment in mice
29. Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes
30. Free-floating adult human brain-derived slice cultures as a model to study the neuronal impact of Alzheimer’s disease-associated Aβ oligomers
31. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease
32. Impaired peripheral glucose homeostasis and Alzheimer's disease
33. Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
34. Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases
35. Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers
36. Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for covid-19 in Brazil
37. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson’s disease-like symptoms in mice
38. Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-β oligomers in mice
39. Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons
40. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice
41. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
42. Brain STAT5 signaling modulates learning and memory formation
43. Stimulation of mRNA translation rescues hippocampal synaptic plasticity and memory in mouse models of Alzheimer’s disease
44. Changes in neurodegeneration and amyloid biomarkers in patients with COVID-19 neurological complications and Alzheimer’s disease
45. Opportunities and challenges in developing relevant animal models for Alzheimer’s disease
46. Extracellular vesicles derived from human Wharton’s jelly mesenchymal stem cells protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers
47. Zika virus replicates in adult human brain tissue and impairs synapses and memory in mice
48. Neonatal infection leads to increased susceptibility to Aβ oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice
49. Alzheimer's disease brain‐derived extracellular vesicles reveal altered synapse‐related proteome and induce cognitive impairment in mice.
50. Alteration in the number of neuronal and non-neuronal cells in mouse models of obesity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.